Tangential Flow Filtration for High-Purity mRNA Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing methods for purifying mRNA molecules are inadequate in removing abortive mRNA fragments and hydrolysis products, which can contaminate downstream applications, particularly in therapeutic contexts, and often involve high salt levels that are difficult to automate.
Innovation Solution
A method using tangential flow filtration (TFF) with sequential purification steps involving a first solution of ammonium acetate, followed by washing and dissolving with water, then using a chelating agent like EDTA in a third solution to remove divalent cations, and finally washing with a fourth solution to obtain purified mRNA.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Manufacturing precision
If conventional purification methods are used, then mRNA molecules can be obtained, but abortive fragments and hydrolysis products remain as contaminants
Solution Approach 1:
The purification process is divided into multiple sequential TFF steps, each targeting specific contaminants: Step 1 removes proteins and cellular debris, Step 2 removes abortive fragments, and Step 3 removes hydrolysis products. This segmented approach allows each filtration step to focus on specific impurities, achieving high overall purity
Solution Approach 2:
Different buffer solutions act as intermediaries between the mRNA and contaminants. Each buffer is specifically designed with pH and ionic strength optimized to facilitate the removal of particular contaminant types while maintaining mRNA stability throughout the sequential purification process
2Manufacturing precision
If high salt concentrations are used in purification, then mRNA can be precipitated, but automation becomes difficult
Solution Approach 1:
The patent replaces manual precipitation and centrifugation operations with automated tangential flow filtration. The TFF system uses controlled transmembrane pressure and cross-flow to achieve separation without requiring high salt concentrations or manual intervention, enabling full automation of the purification process
Solution Approach 2:
The invention changes the purification parameters from high salt concentration precipitation to controlled pH and ionic strength conditions optimized for TFF. Each buffer solution is formulated with specific pH values and ionic compositions that enable effective contaminant removal through filtration while maintaining conditions suitable for automation
3Manufacturing precision
If multiple purification steps are performed, then mRNA purity increases, but processing time increases
Solution Approach 1:
The sequential TFF steps are designed to operate continuously without interruption between stages. The permeate from one step becomes the feed for the next step, eliminating downtime and allowing the purification process to proceed as a continuous operation, reducing total processing time while maintaining high purity
Solution Approach 2:
Multiple purification functions are merged into a single integrated TFF platform. Different filtration membranes with varying pore sizes and selectivities are combined in sequence within the same system, allowing simultaneous achievement of contaminant removal, concentration, and buffer exchange in one continuous process
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The method achieves high-purity mRNA with minimal abortive fragments and salts, suitable for downstream applications, by efficiently removing contaminants through TFF and chelating agents, ensuring stability and suitability for pharmaceutical use.
Implementation Method 1
purifying precipitated mRNA molecules from a suspension comprising precipitated mRNA molecules using a first solution... steps (Ia) to (IIb) are performed using tangential flow filtration
Implementation Method 2
purifying the mRNA molecules from the dissolved mRNA molecules obtained from step (Ib) using a third solution comprising a chelating agent... washing the purified mRNA molecules obtained from step (IIa) using a fourth solution
Data Source
AI summary
The present disclosure provides a method of purifying mRNA molecules comprising (Ia) purifying precipitated mRNA molecules from a suspension comprising precipitated mRNA molecules, (Ib) washing and dissolving the purified precipitated mRNA molecules, (IIa) purifying the mRNA molecules using a solution comprising a chelating agent, followed by (IIb) washing the purified mRNA molecules, wherein steps (Ia) to (IIb) are performed using tangential flow filtration.


